| PATENT REGISTER | |||||||||
| Status | Lapsed | Patent No. | 2047867 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Application No. | 08019249.5 | Date of Filing | 19/06/2003 | ||||||
| Date Grant Published | 22/05/2013 | Application Published | 15/04/2009 | ||||||
| Title of Invention | ACE2 activation for treatment of heart, lung and kidney disease and hypertension | ||||||||
| Priority |
|
||||||||
| Inventors |
Crackower, Michael A. Penninger, Joseph M |
||||||||
| Current Proprietor |
Apeiron Biologics AG Campus-Vienna-Biocenter 5 1030 Wien AUSTRIA |
||||||||
| Earlier Application No. 03729747.0 | Expired | ||||||||
| Publication Language | English | ||||||||
| Translation Received Date | |||||||||
| 24/05/2013 | Divisional Application number: 10178474.2 Publication number: 2332582 Date of receipt: 22/09/2010 | ||||||||
| 07/03/2014 | Patent lapsed due to non-payment of Patent Renewal Fee in respect of year 11. | ||||||||
